Since CD11c is involved in the maturation and/or effector functions of several myeloid-derived cells including neutrophils, DCs, and monocytes, manipulating CD11c would serve as a potential strategy to intervene diseases involving these cells, which include tumor and autoimmune diseases other than acute infectious diseases. Here, ITGAX is linked to neoplasm.